2023 – Page 4

Disclaimer: This page is intended only for persons who reside within India and should not be accessed, or relied upon by individuals residing outside India. The health information contained herein is provided for awareness purposes only, and is not intended to act as a diagnostic tool or to substitute in any manner, the need to seek prompt medical advice from a qualified healthcare professional. All decisions regarding a person’s diagnosis, treatment and care must be made after consultation with a healthcare provider, considering the unique characteristics of the person. While due care and caution has been taken to ensure that the content of this page is free from mistakes or omissions, Pfizer makes no representations or warranties of any kind, expressed or implied; as to the accuracy, completeness or adequacy of the contents on this page and will not be liable for any damages, adverse events, and personal liability arising therefrom.

Yearly Archives: 2023

The Importance of Equity in Addressing Disparities in Health Care

Inappropriate Opioid, Gabapentinoid Prescribing in CKD Still Occurring

Short-Term Improvement in Chronic Pain for Oral Cannabinoids

Restricting Supply Alone Is Not the Answer to the Opioid Crisis

Disparities in Chronic Pain Highly Prevalent Among Multiracial Groups in the US

Younger Age at Menarche Increases Risk for Later Chronic Pain

What is Monkeypox? A Microbiologist Explains What’s Known About This Smallpox Cousin

Distinct Physical, Psychosocial Profiles in Pediatric Patients With Chronic Back Pain

Suvorexant May Ease Symptoms During Opioid Withdrawal Therapy

HIPAA Potentially at Odds With New Laws on Gender-Affirming Care